|
AA13452 |
Cabozantinib s-malate |
1140909-48-3 |
C32H30FN3O10 |
635.5931 |
VIEW DETAILS > |
|
AA25459 |
H-Glu-Trp-OH |
38101-59-6 |
C16H19N3O5 |
333.3392 |
VIEW DETAILS > |
|
AB05096 |
SU5416 |
204005-46-9 |
C15H14N2O |
238.2845 |
VIEW DETAILS > |
|
AB20210 |
3-(2,4-Dimethyl-5-{[(3Z)-2-oxo-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid |
210644-62-5 |
C18H18N2O3 |
310.3471 |
VIEW DETAILS > |
|
AB34476 |
1-{2-Chloro-4-[(6,7-dimethoxyquinazolin-4-yl)oxy]phenyl}-3-propylurea |
286370-15-8 |
C20H21ClN4O4 |
416.8581 |
VIEW DETAILS > |
|
AB50644 |
Foretinib |
849217-64-7 |
C34H34F2N4O6 |
632.6538 |
VIEW DETAILS > |
|
AB52311 |
(3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1h-indole-6-carboxylic acid methyl ester ethanesulfonate |
656247-18-6 |
C33H39N5O7S |
649.7571 |
VIEW DETAILS > |
|
AF31547 |
Pd173074 |
219580-11-7 |
C28H41N7O3 |
523.6702 |
VIEW DETAILS > |
|
AH51110 |
Regorafenib HCl |
835621-07-3 |
C21H16Cl2F4N4O3 |
519.2764 |
VIEW DETAILS > |
|
AI46583 |
4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline |
288383-20-0 |
C25H27FN4O3 |
450.5053 |
VIEW DETAILS > |